mRNA Synthesis

Messenger RNA (mRNA), are molecule in cells that carries codes from the DNA in the nucleus to the sites of protein synthesis in the cytoplasm (the ribosomes). The molecule that would eventually become known as mRNA

Because information in DNA cannot be decoded directly into proteins, it is first transcribed, or copied, into mRNA

Synthetic mRNA comes from a template nucleotide sequence of DNA. The process starts with codon optimization of this sequence for optimal transcription. The gene is synthesized, cloned into a vector, and verified by sequencing. The plasmid DNA is then amplified, target mRNA sequence linearized, and used as a template for in vitro transcription.

CART-T Production

CAT-T Therapy (Chimeric Antigen Receptor), is an immunotherapeutic approach used to program and strengthen the immune system to attack some forms of cancer. It works by collecting a small portion of a patient’s own T-cells from the blood and re-engineering them in a specialized laboratory to carry special structures called chimeric antigen receptors (CARs) on their surface, these altered T-cells when introduced back into patient’s system, these activated T-Cells allow them to recognize cancer cells and eliminate them effectively.

Gene Therapy

Gene therapy is a technique that uses a gene(s) to treat, prevent or cure a disease or medical disorder. Often, gene therapy works by adding new copies of a gene that is broken, or by replacing a defective or missing gene in a patient’s cells with a healthy version of that gene. Both inherited genetic diseases (e.g., hemophilia and sickle cell disease) and acquired disorders (e.g., leukemia) have been treated with gene therapy.

Lab Working Cell Bank 

A working cell bank (WCB) in mRNA production is a collection of cells derived from a single master cell bank and maintained under controlled conditions to ensure the stability and consistency of the cells. These cells are regularly tested for purity and identity to ensure they are free of contaminants. The WCB is subject to strict documentation and traceability requirements to ensure the quality and safety of the mRNA product. The WCB is used to generate mRNA for various downstream applications, such as gene therapy and vaccine production.

• • Freezing bags
  • Cryomedia
  • Culture media

Upstream Process 

The upstream processes in mRNA production involve preparing the mRNA template and producing the RNA polymerase enzyme for transcription. The mRNA template is chemically synthesized and modified for stability and translational efficiency. RNA polymerase is either purified from natural sources or produced recombinantly using bacterial or mammalian expression systems. The gene encoding the enzyme is cloned, transformed, and cultured to produce the enzyme, which is purified and tested for activity and purity. Upstream processes are crucial for producing high-quality mRNA, and any deviations could affect downstream processes and the final product’s quality and efficacy.

• • Suspension Cell Culture in single-use bioreactors 
  • Adherent Cell Culture in multilayer flasks-sanisure
  • Packed-bed bioreactor
  • STR bioreactor suspension
  • Viral sensitizer, Transfection reagents

Downstream Process 

The downstream processes of mRNA production involve purifying and testing the synthesized mRNA for quality, purity, and stability before it can be used in various applications such as gene therapy or vaccine production. The mRNA is purified using various methods to remove impurities, and it undergoes quality control tests to ensure its suitability for downstream applications. Once the mRNA passes all quality control tests, it can be formulated for use. Downstream processes are crucial for the successful production of high-quality mRNA, and any errors or deviations in this stage could impact the final product’s quality and efficacy.

• • Depth filtration system
  • Chromatography systems, Columns, Resins
  • Purification Solutions — Chromatography, and Tangential Flow Filtration system

Aseptic fill and finish 

Aseptic fill and finish is the final step in mRNA production that involves filling purified mRNA into vials or cartridges under sterile conditions. The process includes vial washing, sterilization, filling, and sealing, all of which are carried out under aseptic conditions. The filled vials are inspected for defects and labeled with batch information and expiration dates. This step is critical to ensure the final product is sterile, safe, and effective for use in various applications.

• • Formulation and Final Drug Product manufacturing
  • Automated Aseptic Filling line for live Viral Vectors